Effect of Helicobacter pylori treatment on recurrence of upper gastrointestinal bleeding in patients with atrial fibrillation on anti-thrombotic agents

D. Y. Lee,Beom Joon Kim, J. H. Kim,Seung Yong Shin

Endoscopy(2023)

引用 0|浏览1
暂无评分
摘要
Aims The risk of recurrent gastrointestinal bleeding (GIB) in atrial fibrillation (AF) patients on anti-thrombotic after H. pylori (HP) eradication remains poorly defined. We characterized the incidences of hospitalizations for all recurrent GIB in anti-thrombotic users according to HP eradication therapy ([Table 1]).
更多
查看译文
关键词
helicobacter pylori treatment,atrial fibrillation,upper gastrointestinal bleeding,anti-thrombotic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要